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Abstract: Background: Hyperglycaemia in pregnancy contributes to adverse outcomes for women
and their children. The postpartum period is an opportune time to support women to reduce
cardiometabolic and diabetes risk in subsequent pregnancies. Aims: To identify strengths and gaps
in current care for Aboriginal women after a pregnancy complicated by hyperglycaemia. Methods:
A retrospective review of the 12 month postpartum care provided by primary health centres in
remote Australia in 2013–2014 identified 195 women who experienced hyperglycaemia in pregnancy
(gestational diabetes (GDM) (n = 147), type 2 diabetes (T2D) (n = 39), and unclear diabetes status
(n = 9)). Results: Only 80 women (54%) with GDM had postpartum glycaemic checks. Of these,
32 women were diagnosed with prediabetes (n = 24) or diabetes (n = 8). Compared to women with
GDM, women with T2D were more likely to have their weight measured (75% vs. 52%, p <0.01), and
smoking status documented as “discussed” (65% vs. 34%, p < 0.01). Most women (97%) accessed the
health centre at least once in the 12 month postpartum period but, during these visits, only 52% of
women had service provision, either structured or opportunistic, related to diabetes. Conclusion:
High rates of dysglycaemia among women screened for T2D after GDM in the 12 month postpartum
period highlight the need for increased screening and early intervention to prevent the development
of T2D and its complications. Whilst a clear strength was high postpartum attendance, many women
did not attend health services for diabetes screening or management.
Keywords: type 2 diabetes; gestational diabetes; indigenous health; primary health care; remote
health care
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1. Introduction
Diabetes is at epidemic levels in Indigenous communities, contributing considerably to the life
expectancy gap between Indigenous and non-Indigenous peoples globally [1]. Hyperglycaemia in
pregnancy (which includes gestational diabetes (GDM) and pre-existing type 2 diabetes in pregnancy
(T2D)) is increasing, in parallel with the rise in obesity and T2D in women of reproductive age [2].
Hyperglycaemia in pregnancy is associated with poor pregnancy outcomes [3,4]. Long-term sequelae
in offspring are also noted [5] and include higher risk of diabetes and obesity later in life [4]. For women
with GDM, there is a high risk of developing GDM in subsequent pregnancies and, later, T2D and
cardiovascular disease [6]. The burden of disease is greater for Indigenous women, with higher rates of
GDM and T2D in pregnancy than their non-Indigenous counterparts [7–10]. In Australia, Aboriginal
and Torres Strait Islander women are 1.5 times more likely to have GDM, 10.4 times more likely to
have pre-existing T2D [3], and four times more likely to develop T2D after GDM, compared with
non-Indigenous women [11].
In light of the risks associated with hyperglycaemia in pregnancy, postpartum care is essential
to addressing postpartum glycaemic status and the long-term risk for both women and their future
children. Many women do not present for pre-conception care [12,13] and, hence, the postpartum
(or ‘inter-pregnancy’) period may be the only time for opportunistic health messaging prior to future
pregnancies. It is an ideal time to support women to reduce their risk of developing T2D and recurrent
GDM, or to optimally manage their T2D and other cardiovascular risk factors, with benefits for
both women and their future children [14]. However, there are many barriers to achieving this
objective. Whilst international guidelines recommend all women with GDM undertake a 75 g oral
glucose tolerance test (OGTT) between 6 and 12 weeks after delivery to screen for disorders of glucose
metabolism [15], uptake has been low among non-Indigenous [16,17] and Indigenous women [18,19].
Barriers to the delivery of and access to postpartum care have been reported at various levels.
Health systems factors include inadequate communication between hospitals and health centres about
a diagnosis of hyperglycaemia in pregnancy [16,20] and lack of clarity around who is responsible for
postpartum care [21]. At an individual level, barriers for women include the need to fast and the
unpleasantness of the OGTT, caregiver demands, prioritising the needs of their family ahead of their own
and low perception of the long-term risk associated with hyperglycaemia during pregnancy [22–24].
There are further challenges for women living remotely, including accessible and appropriately
coordinated health care, the high turnover of health professionals (reducing the establishment of
therapeutic relationships and awareness of disease burden) and socioeconomic disadvantage [25,26].
In the Northern Territory (NT), Australia, Aboriginal and Torres Strait Islander peoples comprise
30% of the population with 80% living in remote communities [27]. Standard practice for pregnant
women living remotely in the NT is to be transferred from their community to a regional centre at
37–38 weeks gestation to birth in a hospital [28]. During the early postpartum period, most mothers
and their babies return to their community and their health care is provided by their local health
centres. In the remote setting, there has been limited research into postpartum management after
a pregnancy complicated by hyperglycaemia. We aim to identify strengths and gaps in current care for
Aboriginal women after a pregnancy with hyperglycaemia to inform the design of a health systems
intervention to improve postpartum care and reduce long-term complications.
2. Materials and Methods
2.1. Study Population
In the NT, remote health care is provided by Aboriginal community controlled health services or
the NT Department of Health. The study sites for this review were the remote centres across the NT
managed by the NT Department of Health; this included both The Top End (north of Elliot including
Tiwi Islands and East Arnhem Land) and Central Australia (including and south of Elliot, including
the Barkly region). The study was conducted in accordance with the Declaration of Helsinki and was
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approved by the Human Research Ethics Committee of the NT Department of Health and Menzies
School of Health Research (HREC-2015-2461), and the Central Australian Human Research Ethics
Committee (HREC-15-345).
2.2. Data Collection
We requested de-identified medical records of all women with a diagnosis of hyperglycaemia
in pregnancy (as classified by International Classification of Primary Care (ICPC) codes), who had
an antenatal care plan with a birth due date between 1 January 2013 and 31 December 2014. The medical
records of 201 women, in 48 different communities, with a diagnosis of hyperglycaemia in pregnancy
were assessed. Two women each had two pregnancies and live births during the study period; both
pregnancies were included. Four women did not have a confirmed diagnosis of hyperglycaemia in
pregnancy and two women appeared to have left the community before birth and did not receive
postpartum care in the study communities. These women were excluded from analysis, resulting in
197 entries analysed. Of these women, 75% had GDM, 20% had T2D in pregnancy, no women had type
1 diabetes and 5% had unclear diabetes status during pregnancy.
Within this dataset, information collected included baseline characteristics of women (age, ethnicity,
type of diabetes, diabetes medication use during pregnancy and locality), and health care delivered
in the 12 months following the baby’s date of birth. Relevant data had predominantly been entered,
and was therefore extracted, from care plan templates within the electronic health record (for example
a chronic condition care plan) developed in line with best practice guidelines. At the time of this study,
guidelines recommended all women have a six-week postpartum check-up and for women with GDM
an OGTT be performed [29]. Women with T2D were recommended to commence a chronic condition
care plan—involving cardiovascular risk assessment and health checks at least yearly, depending on
their level of cardiovascular risk. Women with GDM were recommended to have regular Adult Health
Checks—involving a comprehensive health assessment, and yearly glycated haemoglobin (HbA1C)
and blood glucose levels [29,30].
2.3. Outcome Measures
The outcomes of interest were rates of (1) glycaemic checks performed within the 12 month
postpartum period (HbA1C or OGTT), (2) routine six-week postpartum check-ups, (3) commencement
of care plans (either Chronic Disease Care Plans or Adults Health Checks) within the 12 month
postpartum period, (4) documentation of weight and height measured, body mass index (BMI)
calculated, breastfeeding “discussed”, smoking status “discussed” and contraception commenced
or “discussed” within the 12 month postpartum period (either prior to, during, or after the six-week
postpartum check-up) and (5) recorded outcomes of relevant health checks among women who had
the above-mentioned measurements or discussions. To determine whether other attendances were
used opportunistically for delivery of diabetes screening and management, information on all other
attendances at health centres was noted.
2.4. Outcome Variable Definitions
In the 12 month postpartum period, women were classified as having T2D if they had either
a diagnostic OGTT (fasting plasma glucose ≥7.0 mmol/L or 2-h plasma glucose ≥11.1 mmol/L), or an
HbA1C ≥6.5% (48 mmol/mol). Prediabetes was considered present if fasting plasma glucose was
≥6.1 and <7.0 mmol/L or 2-h plasma glucose was ≥7.8 and <11.1 mmol/L or HbA1C ≥5.7% and
<6.5% (39–47 mmol/mol) [31]. Postpartum dysglycaemia was defined as either prediabetes or diabetes.
Overweight was defined as BMI 25.0–29.9 kg/m2 and obesity defined as BMI ≥30 kg/m2. Contraception
commenced or “discussed” was defined as any evidence of initiation of contraception, including
in hospital immediately postpartum, or any consultation where contraception was documented as
discussed. In cases when contraception use changed over the 12 month postpartum period, the initial
type of contraception used was recorded as ‘contraception use’. A diabetes-related visit was defined
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as any visit where, either scheduled or opportunistically, (1) an HbA1C or OGTT was performed,
(2) a diabetes-related health professional was seen (diabetes educator, endocrinologist, podiatrist,
optometrist), or (3) preventative health advice related to diabetes was given and recorded. A visit
where only a random blood glucose was performed was also reviewed, but not included in the main
analyses. A visit where only the child was seen was not recorded.
2.5. Statistical Analysis
Differences in independent variables and outcomes were determined using Pearson chi square
tests for categorical variables, Student’s t-test for normally distributed continuous variables and
Wilcoxon rank sum tests for non-normally distributed continuous variables. p values < 0.05 indicated
statistically significant associations or differences. STATA software V 15.0 (Stata Corporation, College
Station, TX, USA) was used to carry out statistical analyses.
3. Results
Compared to women with GDM, women with T2D were older, more likely to live in Central
Australia than the Top End of the NT and had higher postpartum HbA1C and capillary glucose levels
(Table 1).
Table 1. Characteristics of women following hyperglycaemia in pregnancy and their postpartum results
at any time point in the 12 month postpartum period in the Northern Territory, 2013–2014.
Maternal Characteristics AllPregnancies GDM T2D
p-Value by
Diabetes Type
Number a 197 b 148 40
Age, mean (SD) 28.7 (6.3) 27.8 (6.2) 32 (5) <0.001
Ethnicity, n (%)
Aboriginal 188 (95.5) 139 (93.9) 40 (100)
Torres Strait Islander 1 (<1) 1 (0.7) 0
Non-Indigenous 8 (4) 8 (5.4) 0
Geographic location, n (%)
<0.001Top End 130 (66) 107 (72.3) 17 (42.5)
Central Australia 67 (34) 41 (27.7) 23 (57.5)
Glycaemic testing results n= 46
4.4 [4.1, 5]) NA
OGTT fasting mmol/L median (IQR) 5.6 [5.2, 8.2] NA
OGTT 2 h mmol/L median (IQR) n = 88 n = 54 n = 31
<0.001HbA1C % mean (SD) 6.4 (1.5) 6.0 (1.1) 7.3 (1.9)
HbA1C mmol/mol mean (SD) 46.8 (16.5) 42.1 (11.7) 56.0 (20.3)
Diabetes treatment, n (%)
<0.001
Diet only 110 (56) 94 (63) 8 (20)
Metformin only 48 (24) 32 (22) 15 (37)
Insulin only 8 (4) 5 (3) 3 (8)
Metformin and insulin 31 (16) 17 (12) 14 (35)
Weight kg mean (SD) c n = 113 n = 77 n = 30 0.192772.0 (15.5) 70.9 (17) 75.3 (10.9)
BMI kg/m2 mean (SD)
n = 80 n = 49 n = 26
0.101327.5 (4.9) 26.9 (5.3) 28.9 (4)
Number of women breastfeeding, n (%) d
n = 117 n = 92 n = 21
0.283104 (88.9) 80 (87) 20 (95.2)
Smoking status e n = 81 n = 50 n = 26 0.25742 (51) 28 (56) 11 (42.3)
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Table 1. Cont.
Maternal Characteristics AllPregnancies GDM T2D
p-Value by
Diabetes Type
Contraception use f n = 132 n = 106 n = 22
0.809No contraception, n (%) 9 (8) 7 (6.6) 2 (9)
Implanon, n (%) 84 (63) 70 (66) 13 (59)
Other g, n (%) 39 (29) 29 (27.4) 7 (31.8)
Abbreviations: GDM, gestational diabetes; T2D, type 2 diabetes; SD, standard deviation; OGTT, 75 g oral glucose
tolerance test; IQR, interquartile range; HbA1C, glycated haemoglobin; BMI, body mass index. a All results
(glycaemic testing results, weight and BMI measurement, number of women breastfeeding or smoking or using
contraception) are the results in those women who had measurements recorded or conversations discussed.
b 9 women unclear whether GDM or T2D in pregnancy. c Median time weight or BMI measured: 151 days
postpartum [IQR 82, 245]. d Median time breastfeeding discussed: 12 days postpartum [IQR 8, 23]. e Median time
smoking discussed: 180 days postpartum [IQR 103, 267]. f Median time contraception initiated or discussed: 47 days
postpartum [IQR 16, 68]. g Includes depo provera, tubal ligation, oral contraceptive pill and condoms.
3.1. Postpartum Glycaemic Checks
Among women with GDM, 54% (n = 80) had either an OGTT, HbA1C or both in the 12 month
postpartum period. Thirty-one percent (n = 46) of women with GDM had a postpartum OGTT, with
the median time to OGTT being 10.4 weeks postpartum [IQR 7.3–19.3]. Twelve percent (n = 17) had
an OGTT within two months postpartum, as is recommended. Twenty-three percent of women (n = 34)
had an HbA1C at least 4 months postpartum or later, as recommended. An additional 15% (n = 22)
had an HbA1C earlier than the recommended 4 months postpartum (if an HbA1C is performed earlier
than 4 months postpartum, the results will be influenced by the pregnant state) [32] (Figure 1). There
were no differences in age, BMI, or rates of smoking and breastfeeding among women who were and
were not screened for dysglycaemia. Women who were screened were more likely to have been using
insulin during pregnancy (24% vs. 11%, p = 0.04), to have breastfeeding “discussed” (78% vs. 55%,
p < 0.01), smoking “discussed” (46% vs. 28%, p = 0.04) contraception commenced or “discussed” (89%
vs. 64%, p < 0.01) and have had a six-week postnatal check (89% vs. 71%, p = 0.01). However, women
who were screened were no more likely to be on a health care plan, compared to women who were
not screened.
Figure 1. Glycaemic checks performed following hyperglycaemia in pregnancy at any time point in
the 12 month postpartum period, in the Northern Territory, 2013–2014, by diabetes in pregnancy type.
Data are percentages.
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Of the 54% of women (n = 80) with GDM who had either a postpartum OGTT or HbA1C, 31%
(n = 24) were diagnosed with prediabetes and 10% (n = 8) were diagnosed with T2D. Differences
between women who did and did not develop dysglycaemia are described in Table 2. Women
diagnosed with postpartum dysglycaemia had a higher BMI (29.0 kg/m2 (5.3) vs. 24.5 (5.3), p = 0.01)
and were more likely to be using insulin in pregnancy (34% vs. 17%, p = 0.86) though this did not
reach statistical significance, compared to women with postpartum normoglycaemia. There was no
difference in age between these two groups.
Table 2. Differences between women who did and did not develop postpartum dysglycaemia, among
women with GDM who were screened postpartum.
Characteristics GDM PostpartumNormoglycaemia (n = 48)
GDM Postpartum
Dysglycaemia (n = 32)
Comparison
(p-Value)
Age years, mean (SD) 28 (6.0) 29 (6.5) 0.456
Prediabetes, n (%) - 8 (25)
Diabetes, n (%) - 24 (75)
Ethnicity, n (%)
Aboriginal 46 (96%) 31 (97%)
Torres Strait Islander 0 1 (3%)
Non-Indigenous 2 (4%) 0
BMI, kg/m2, mean (SD) 24.5 (5.3) 29.0 (5.3) 0.01
Insulin use during pregnancy, n (%) 8 (17) 11 (34) 0.086
OGTT fasting mmol/L, median (IQR) 4.4 (4.1–4.9) 4.8 (4.2–6.8) 0.146
OGTT 2 h mmol/L, median (IQR) 5.5 (4.9–6) 9.1 (8.3–11.4) <0.01
HbA1C %, mean (SD) 5.5 (0.30) 6.5 (1.3) <0.01
HbA1C mmol/mol, mean (SD) 36.2 (3.3) 47.5 (13.9) <0.01
3.2. Completion of Six-Week Postpartum Check-Up and Health Care Provided within 12 Months Postpartum
In the 12 month postpartum period, 58% of women (n = 115) had a documented specific six-week
postnatal check at the health centre, with the median time to review being 7.4 weeks postpartum [IQR
4.6, 10]. Neither age nor diabetes type was associated with the odds of having a six-week postnatal
check between women with T2D and GDM, though women living in the Top End were more likely to
have a six-week postnatal check (67% vs. 42%, p < 0.01) compared to those living in Central Australia.
Within the 12 months postpartum, 25% of women (n = 50) were either previously on or commenced
a chronic condition care plan and 26% (n = 51) had an Adult Health Check. Women on a Care Plan
were more likely to be older (30 years (6.5) vs. 28 (5.9), p = 0.02) and live in Central Australia (61% vs.
46% in the Top End, p = 0.04). Eighty-three percent of women with T2D (n = 33) were appropriately
either already on a chronic condition care plan, or newly started a chronic condition care plan in the
12 month postpartum period (the remaining 17% were on no care plan) (Figure 2).
Of the 41% of women (n = 80) who had a BMI measured, 43% (n = 34) were classified as overweight
and 29% (n = 23) classified as obese. There were no differences in age between women who did and
did not have breastfeeding and contraception documented as “discussed”, whilst older women were
more likely to have their weight or BMI measured (30 years (6.2) vs. 27 (6.0), p < 0.01) and smoking
“discussed” (30 years (6.4) vs. 28 (5.9), p < 0.01). Women living in the Top End were more likely to have
breastfeeding “discussed” (68% vs. 43%, p < 0.01), and there were no differences by region in the odds
of having BMI or weight measured or smoking and contraception “discussed”.
When comparing women with GDM versus T2D, there were no differences in BMI, although
women with T2D were more likely to have had their weight or BMI measured and smoking status
documented as “discussed”, and less likely to have contraception commenced or “discussed” There
were no differences in whether breastfeeding was “discussed” (Figure 2). In the 67% of women (n = 132)
who had contraception commenced or “discussed”, the majority (63%) were prescribed Implanon,
with no differences in rates of contraception use between women with T2D or GDM (Table 1).
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Figure 2. Health care delivered following hyperglycaemia in pregnancy at any time point in the
12 month postpartum period in the Northern Territory, 2013–2014, by diabetes in pregnancy type. Data
are percentages. Postnatal Care: Best practice guidelines recommended all women postpartum to have
a six-week postnatal check-up. Health care plan: Best practice guidelines recommended women with
T2D commence a chronic condition care plan and women with GDM have second yearly adult health
checks- both of which form a health care plan.
3.3. Visits to Primary Health Centre and Reasons for Visit
Among the 97% of women (n = 192) who visited the health centre in the 12 month postpartum
period, the median number of visits was 10 [IQR 6, 17]. However, 48% of women (n = 93) who visited
the centre in the 12 month postpartum period had no diabetes-related visits (either an opportunistic or
scheduled diabetes-related consultation). Women with T2D were more likely to have a diabetes-related
visit than women with GDM, 80% (n = 32) compared with 42% (n = 62) (Figure 3).
Figure 3. Number of visits to the health centre following diabetes in pregnancy in the 12 month
postpartum period in the Northern Territory, 2013–2014, by diabetes in pregnancy type. Data are
percentages. * As a percentage of all women in the study. ˆ As a percentage of women who had any
visit to the clinic in the 12 month postpartum period. BGL, blood glucose level.
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4. Discussion
In this study, we reviewed the provision of recommended postpartum care, including routine
six-week postnatal check-ups, screening for diabetes and care plans provided to women with
hyperglycaemia in pregnancy in remote communities across the NT. This population is at high
risk for adverse cardiometabolic outcomes, with a high proportion of women with hyperglycaemia
having T2D (20%) compared with GDM, higher than reported nationally (10% in 2014–2015) [33].
In this study, general health centre attendance was high in the 12 month postpartum period. Women
with GDM had low rates of postpartum screening for T2D and in those women who were screened,
rates of dysglycaemia were high. Women with T2D were more likely to be seen in the postpartum
period for reasons related to diabetes, and more likely to have their weight measured and smoking
“discussed” compared with women with GDM.
We report low rates of postpartum OGTT screening in women with GDM (31%) at 12 months,
although these rates are higher than the 14% reported in Aboriginal women in Far North Queensland [18],
and consistent with globally low rates [34]. Some predictors of higher likelihood of postpartum screening
have been reported such as older age, lower BMI, Europid ethnicity, insulin use during pregnancy and
higher socioeconomic status [35–37]. In our cohort of women of mostly non-Europid ethnicity with
lower socioeconomic status, we report no differences in age or BMI between women who were and were
not screened, although women who were screened were more likely to be on insulin during pregnancy.
The issue of low postpartum OGTT testing raises similar concerns to those raised by low rates of
OGTT screening for GDM during pregnancy reported in regional and remote Western Australia [38].
Among women who were screened for T2D, we report a 10% rate of T2D at 12 months postpartum.
Chamberlain reports a 22% rate of conversion at 3 years among Aboriginal women in Far North
Queensland [11]. In this context, it is critical that we improve adherence to OGTT screening guidelines
both during pregnancy and after pregnancy and enable this high-risk group to access timely intervention.
It also raises the question as to whether alternate screening strategies that are less cumbersome such
as an HbA1C or a risk prediction tool can be further explored [38]. Indeed, whilst reportedly less
sensitive [39,40], but cheaper and more convenient, guidelines in regional and remote NT now (after
this study period) recommend an HbA1C four months postpartum if an OGTT is not able to be
performed [41].
T2D is a serious metabolic condition associated with complications in subsequent pregnancies for
the mother and her baby [42]. Contraception discussion and pregnancy planning is critical, particularly
given that the degree of hyperglycaemia in early pregnancy correlates with the risk of congenital
anomalies in offspring [43]. Among women where contraception was “discussed”, most were using
some form of contraception, consistent with a desire for control over family planning and access to
postpartum contraception, as reported by Aboriginal women in Queensland [44]. T2D is also associated
with other cardiometabolic risk factors and causes numerous complications including cardiovascular
disease, chronic kidney disease, neuropathy, retinopathy and peripheral vascular disease [45]. Given
this, it is encouraging that women with T2D had relatively high rates of documented weight or BMI
measured, or smoking “discussed”. Most women with T2D were also on a chronic condition care
plan involving regular cardiovascular risk assessment and health checks. This is reassuring as there is
evidence that diabetes care plans result in improved quality of care and cost savings [46]. Specifically,
in remote NT communities, it has been shown that a delay from diagnosis to commencement of
a diabetes care plan is associated with worse outcomes [47].
Fifty-eight percent of women had a six-week postnatal check, which is substantially better than
the 33% documented in 2004–2006 in two remote communities in the NT [48]. Most women in our
study (97%) accessed the health centre at some point in the 12 month postpartum period, although
there was a significant minority (48%) who accessed the centre multiple times with no documented
service provision related to their hyperglycaemia in pregnancy. Most of these women had GDM
rather than T2D, perhaps highlighting the lack of awareness of risk associated with GDM. A study
of Aboriginal women in South Australia accessing health care in the postpartum period reported
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women who had GDM were no more likely than women without diabetes to have contact with primary
care practitioners in the postpartum period [49]. This suggests that these women were not identified,
by themselves or by health professionals, as being at elevated risk.
Health professionals report uncertainty around whose role it is to follow up women with GDM [21]
and poor coordination between hospitals and remote health services in the transfer of mother and
infant care [50]. Qualitative work with Aboriginal and Torres Strait Islander women and their health
professionals in Queensland describes the problem of both women and health professionals not
knowing who had GDM and hence who required specific postpartum diabetes care [23]. Studies
in women with pre-existing T2D have shown that, despite better glycaemic management during
pregnancy, HbA1C values after pregnancy usually worsen [51,52], highlighting the gap in continuous
inter-pregnancy care. Continuity of care is also likely impacted by staffing patterns in remote health
centres. There is high staff turnover and a reliance on locum or agency staff, reflecting the difficulties
in recruitment and retention of health workers in remote communities [53,54].
The Diabetes across the Lifecourse Northern Australia Partnership aims to improve health
outcomes for women with hyperglycaemia in pregnancy and their children [12]. This review, coupled
with formative work [21,55], will inform the development of a complex health systems intervention
in the NT and Far North Queensland which includes improving information management and
communication, access to culturally appropriate care and increasing workforce capacity and health
literacy of health professionals. In 2017, specific Diabetes in Pregnancy Care Plans were introduced
with recalls scheduled in the electronic medical records for postpartum OGTT testing. The timeframe
chosen for this baseline study is prior to the introduction of this intervention with the aim to reassess
these results after the intervention.
There were several limitations to our study. Data were entered by individual health professionals
and thus have potential for human error and missing data. Given the de-identified nature of this
data we were unable to perform any cross referencing. We also did not have information on neonatal
outcomes. Not all care provided, such as point-of-care HbA1C testing or discussions around smoking
cessation, may have been documented; however, even if this is the case, it is important to highlight
the need for documentation to understand what sort of health messaging and interventions are
taking place. Some discussions may have been documented on the progress notes which would
not be captured by an audit of electronic medical records. In addition, women may have moved
locations during the period of data collection and may be erroneously recorded as having not received
recommended follow-up. The strengths of this study are that we report on real-world rates of
postpartum checks and report delivery of key health messages among women who are at high risk for
adverse cardiometabolic outcomes.
5. Conclusions
In this high-risk population of Aboriginal women with hyperglycaemia in pregnancy, we have
described strengths and gaps in postpartum care. Strengths of care reported in this study include high
rates of postpartum health centre attendance. Among women with GDM, consistent with other studies,
we report low rates of postpartum diabetes screening. Further, in women who had screening, there
were high rates of dysglycaemia. These findings highlight a gap and opportunity to work towards
increased screening and early postpartum health messaging to prevent diabetes and its complications
for these women and future pregnancies.
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